Skip to content

Press Release · Press Releases

Pyramid Pharma Services Adds 13th Commercial Product Through Expanded Partnership With Longstanding Customer

Issued by PR Newswire

Image: PR Newswire

New cartridge-based program supports a therapy approved to treat rare blood cancers. COSTA MESA, Calif., Nov. 3, 2026 /PRNewswire/ -- Pyramid Pharma Services, a U.S.-based contract development and manufacturing organization (CDMO) specializing in sterile injectable drug products,...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories

Press Release

Sempra Reports Strong Third-Quarter 2026 Results

Advancing 2026 Value Creation Initiatives Updating 2026 GAAP EPS guidance range Guiding to high-end of 2026 adjusted EPS guidance range Announcing expected 20% increase to Oncor's base capital plan SAN DIEGO, Nov. 5, 2026 /PRNewswire/ -- Sempra (NYSE: SRE) today reported third-quarter...

PR Newswire ·